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Abstract
Introduction: The indications for a total pancreatectomy (TP), its peri-operative management, provision
of pancreatic surgical services and medical treatment of the inherent exo- and endocrine deficient states
have all changed considerably over recent decades. The effects of these upon the incidence, indications
for and outcomes of TP are unclear. Patients undergoing TP at a single institution over a quarter of a
century were reviewed to try to address these issues.
Methods: Data on patients who underwent elective (el-) and emergency TP (em-TP) between 1987 and
2013 were reviewed. Patient demographics, indications, intra-operative details, peri-operative manage-
ment and long-term outcomes were analysed. Absolute numbers of TP were reported relative to partial
pancreatectomy rates.
Results: In total, 136 patients underwent TP [98 (72.1%) el-TP; 38 (27.9%) em-TP]. There was a
significant change in indication for el-TP with it increasingly performed for (an intraductal papillary
mucinous neoplasm (IPMN) and renal cell metastases whereas there was a decrease in the number of
el-TP performed for chronic pancreatitis (P = 0.025). The relative rates of el-TP, however, did not change
significantly across the study period (P = 0.225). The median length of stay after el-TP decreased from 19
days pre-1997 to 12 days post-1997 (P = 0.009). The relative use of em-TP declined by 0.28 percentage
points per year [P = 0.018; 95% confidence interval (CI): 0.04–0.41].
Conclusions: The indications for el-TP have changed; it is being performed more frequently although
the proportion relative to other pancreatic resections has not changed. A decrease in the rate of em-TP
is likely to reflect improved peri-operative management of a pancreatic fistula and its complications after
a pancreaticoduodenectomy.
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Introduction
Enthusiasm for a total pancreatectomy (TP) has varied with time.
Early interest in elective TP (el-TP) as a potential solution to the
high rates of tumour recurrence after a partial pancreatectomy
waned with a clearer understanding of the tumour biology of
pancreatic adenocarcinoma.1 More recently, however, interest in
el-TP has been replaced by alternative indications for the pro-
cedure, with increasing recognition of multifocal parenchymal
diseases including intraductal papillary mucinous neoplasms
(IPMNs), multifocal renal cell metastases, multifocal
neuroendocrine tumours (NET) and inherited neoplastic dis-
eases, including multiple endocrine neoplasia (MEN)1, prompt-
ing clinicians to re-evaluate the role of el-TP.2,3 A further
indication for TP is in the emergency setting (em-TP), where a
completion pancreatectomy can be performed as a method
of sepsis control in cases of a post-operative pancreatic
fistula (POPF) after a partial pancreatectomy. Improvements in
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cross-sectional radiology and the ability to perform percutaneous
drainage of intra-abdominal collections, however, have provided
alternative methods of sepsis control in this setting.
The post operative exo- and endocrine deficient states have
always tempered enthusiasm for TP. The diabetic state has been
considered so severe it has been termed ‘brittle diabetes’. However,
in recent years, improvements in insulin regimens and specialist
nurse-led diabetic care have dramatically improved diabetic out-
comes post TP.4–8 There is now debate over the actual severity of
the diabetic state, with several groups reporting equivalent HbA1c
levels between type 1 diabetics and TP patients.4–8
The development of high-quality enzyme replacement formu-
lations has also improved morbidity from exocrine insufficiency.
Given the changing indications for elective surgery, an evolu-
tion in the understanding of POPF and sepsis control and medical
management of the inherent exo- and endocrine deficient states
after TP, the present study aimed to review indications and trends
in both el-TP and em-TP at a single institution with a dedicated
pancreatic surgical service over a quarter of a century.
Patients and methods
This study considers two distinct scenarios, el-TP and em-TP.
Both indications are considered in this study to contrast potential
enthusiasm for differing indications for TP within the same insti-
tution over a prolonged period to review trends in managing
various pancreatic diseases and complications.
Data collection
All patients undergoing a partial or total pancreatic resection [TP,
distal pancreatectomy (DP) and pancreaticoduodenectomy (PD)]
between January 1987 and December 2013 were identified from a
prospectively maintained institutional database. El-TP included
single-stage planned elective or single-stage unplanned elective
TP where an intra-operative decision to perform TP and not a
partial pancreatectomy was made. Patients who had previously
undergone a partial pancreatectomy with a subsequent elective
completion pancreatectomy were also included in the el-TP
group. Em-TP was defined as a completion pancreatectomy per-
formed after a previous partial pancreatectomy in order to control
or treat sepsis. The rates of partial pancreatic resection were
observed and compared with the rates of el-TP and em-TP to
understand changes in the proportion of these operations over
time.
Data on patient demographics, indications for surgery, pathol-
ogy, peri-operative complications and long-term outcomes were
retrieved from the database for all TP patients. Data accuracy was
confirmed by retrospective review of patient records.
Follow-up of patients consisted of clinical review every 4–6
months for 2 years with at least an annual follow-up until 5 years.
Follow-up aimed to assess evidence of tumour recurrence and
survival. Sequelae of endocrine insufficiency and post-operative
quality of life have been reported elsewhere.9
Statistical analysis
The relationships between pre-surgical factors, and the outcomes
of overall survival, complication rates and lengths of hospital stay
were assessed separately for patients undergoing el- and em-TP.
Survival analysis was performed using Kaplan–Meier survival
curves, with Log-Rank significance tests. Complication rates
were compared across factors using Fisher’s exact test. As the
distribution of lengths of hospital stay was highly skewed, a non-
parametric approach to analysis was employed. The Mann–
Whitney and Kruskal–Wallis tests were used, depending on the
number of groups be compared, and data were summarized using
medians and quartiles.
The trends over time in frequency and relative rates of pancre-
atic resection were then compared using linear regression models.
The year number was included as the independent variable, and
either the number of operations, or relative proportion of opera-
tions entered as the dependent variable. When working with pro-
portions, the denominator was set as a weighting variable, in order
to give greater influence to percentages based on a greater number
of patients. The resulting coefficients represented the year-on-year
increase in operations or the percentage point change in propor-
tions, respectively.
All analyses were performed using IBM SPSS 19 (IBM Corp.,
Armonk, NY, USA), with P < 0.05 indicative of statistical signifi-
cance. A medical statistician (J.H.) provided advice on study
design and with data analysis.
Results
Study population
Some 1609 pancreatic resections were performed comprising of
1232 PD (76.5%), 241 DP (15.0%) and 136 TP (8.4%). Of the TP
group 98 were el-TP (72.1%) and 38 em-TP (27.9%).
Elective TP
In total, 80 (82%) patients underwent a single-stage planned
el-TP, 11 (11%) a single-stage unplanned el-TP, and a 7 (7%)
elective completion pancreatectomy. An intra-operative decision
was made to convert from a PD to a TP in 11 patients owing to
evidence of tumour deposits (macroscopic or microscopic)
beyond the neck of the pancreas (6), need for extensive venous
reconstruction (3), inadvertent arterial damage (1), or findings of
a soft pancreas deemed unsuitable for anastomosis (1).
The median age of patients undergoing el-TP was 63 years
(range 18–84) and 53/98 (54.1%) were male. El-TP was per-
formed for adenocarcinoma (45; 46%), NET (8; 8%), chronic
pancreatitis (18; 18%), trauma (1; 1%), IPMN (12; 12%), renal
cell metastases (10; 10%), benign lesions (3; 3%) and other malig-
nant lesions (1; 1%).
The median follow-up was 8.4 years, and at last follow-up, 61
(62.2%) patients had died. Post-operative mortality did not
change significantly over time (P = 0.763). A total of 12 patients
(KM estimate 12.5%) died within 90 days of surgery owing to
abdominal sepsis (4), pneumonia (4), myocardial infarction (1),
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intracerebral haemorrhage (1), hypoglycaemic cerebral injury (1)
and Clostridium difficile colitis (1).
The median length of stay was 13 days [interquartile range
(IQR) 9–39 days] and decreased over time from 19 days pre-1997
to 12 days post-2006 (P = 0.009). Post-operative complications
occurred in 45/98 (46.0%) patients. Complication rates were not
significantly associated with pathology (P = 0.084), patient demo-
graphics (gender: P = 1.000, age: P = 0.135) or year of surgery
(P = 0.851). The commonest complication was pulmonary sepsis
(14; 14%), others included post-operative haemorrhage (5; 5%),
biliary obstruction (1; 1%), bile leak (1; 1%) and thrombosis of a
reconstructed portal vein in one patient from three who under-
went venous reconstruction.
Emergency TP
In total, 38 patients underwent em-TP after a prior pan-
creaticoduodenectomy. The median age was 63 years (range
17–81), and 25 patients were male and 13 female. A total of 20
patients died within 90 days of the operation (KM estimate
47.4%), and there was no significant change in survival over time
(P = 0.537).
Themedian length of stay after em-TPwas 27 days (IQR 13–48)
and this did not vary significantly across the study period (P =
0.443). Post-operative complications occurred in 30/38 patients
although this rate reflects morbidity incurred from the prior
pancreaticoduodenectomy which necessitated the em-TP.
The year of surgery and underlying pathology were not found
to be significantly associated with 90-day survival, complication
rates or length of stay after univariate analysis. However, older
patients were shown to have significantly lower survival rates
(P = 0.025), higher complication rates (P = 0.042) and longer
inpatient stays (P = 0.018).
Comparison of outcomes after elective and
emergency TP
Patients undergoing em-TP were more likely to suffer complica-
tions (46% versus 79%) (P = 0.001) and have a longer hospital stay
[27 (IQR: 13–48) versus 13 (9–19) days, P < 0.001] than el-TP
patients. Emergency TP patients also had significantly shorter
survival (P = 0.003), with a Kaplan–Meier estimated 5-year sur-
vival of 15.5%, compared with 36.7% in el-TP.
Changes in trends of TP over time
Absolute annual numbers of TP (elective and emergency)
increased steadily across the study period, by a mean of 0.28 per
year (95% CI: 0.16–0.41, P < 0.001) (Fig. 1a). The number of
partial pancreatic resections also increased, and at a faster rate of
4.3 per year (95% CI: 3.5–5.0, P < 0.001). The rise in total TP was
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Figure 1 (a) Annual numbers of pancreatic resections. The total of total pancreatectomies (TP) includes both elective and emergency cases.
(b) Annual numbers of elective and emergency TP. (c) Elective TP as a proportion of partial resections [pancreatoduodenectomy/ distal
pancreatectomy (DP)]. (d) Emergency CP as a proportion of pancreatoduodenectomy
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predominantly due to the increase in the number of elective
patients of 0.25 per year (95% CI: 0.14–0.35, P < 0.001) (Fig. 1b).
The number of emergency procedures performed annually did
not change significantly over the period (coefficient: 0.04 per year,
95% CI: −0.02–0.01, P = 0.227).
Figure 1c illustrates that the rate of el-TP as a proportion of
partial pancreatic resections showed no significant trend across
the study period (P = 0.225). However, em-TP, as a proportion of
PD (Fig. 1d) demonstrated a significant decline (P = 0.018). This
was equivalent to a reduction of 0.28 percentage points per year
(95% CI: 0.04–0.41).
The surgical drainage rate was found to have significantly
declined over the period of the study (P = 0.002), with a reduction
of 0.4 percentage points per year (95% CI: 0.2–0.7) (Fig. 2a).
Radiological drainage and embolization rates were negligible for
the majority of the study period (Fig. 2b,c). Hence, the analysis
was split into two eras: 1987–2004 and 2005–2013. From 2005
onwards, both rates were found to increase significantly, by 2.0
percentage points per year (95% CI: 0.8–3.1, P = 0.003) for radio-
logical drainage, and 0.8 percentage points per year (95% CI:
0.2–1.5, P = 0.013) for embolization.
The underlying pathology amongst patients undergoing TP
changed significantly across the study period (P = 0.025) with an
increase in el-TP performed pre-1997 and post-2006, respectively,
for IPMN,NET and renal cell metastases and a decrease in chronic
pancreatitis (Fig. 3).
Discussion
This study reports trends in indications and outcomes for patients
undergoing el- or em-TP at a single centre with a dedicated pan-
creatic surgical team over a quarter of a century. El-TP increased
in absolute terms across the study period although did not change
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Figure 3 Trends in indications for elective total pancreatectomy (TP).
The distribution of pathology changed significantly across the study
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Figure 2 (a) Annual rates of (a) surgical drainage, (b) percutaneous drainage and (c) embolization relative to the number of patients
undergoing a pancreaticoduodenectomy across the study period
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significantly, relative to partial pancreatectomy rates. A marked
change was observed in indications for el-TP owing to increased
recognition of multi-focal parenchymal diseases including IPMN,
NET and renal cell metastases, and a decline in the role of el-TP in
chronic pancreatitis.
International consensus guidelines for the management of
IPMN recommend resection for main duct disease with clearance
of all high-grade dysplasia (HGD).10 As main duct IPMN may be
associated with extensive multifocal HGD, the role of el-TP in this
setting is increasingly recognized. The decision to perform el-TP
may be made pre-operatively based on imaging (EUS, MRI, CT),
or intra-operatively in patients with positive margins on frozen
section. In the present study, the existence of main duct IPMN
accounted for 22% of el-TP performed since 2007, a significant
increase on previous years (Fig. 3).
Murphy et al. reported increasing nationwide utilization of
el-TP in the US between 1998 and 2006.11 Although trends in
indications were not reported, the authors concluded the rise in
el-TP was a consequence of increased diagnosis of diffuse neo-
plastic diseases, particularly IPMN, and improved peri-operative
outcomes.
Early post-operative morbidity after el-TP remains high. In the
present study, 46% of patients developed a complication after
el-TP. This is consistent with rates of 32% to 54% reported else-
where.1,5,7,12,13 Ninety-day mortality across the study period was
12.5% which is comparable to a US national audit of el-TP,
which reported an in-hospital mortality of 8.5% between 1998
and 2006. The 90-day mortality since 2006 in the present study
was 8.8%.
The severity of post TP diabetes, and existence of ‘brittle dia-
betes’ as a particularly difficult to control diabetic state, is an area
of debate. Emerging evidence questions the existence of ‘brittle
diabetes’ after TP. Case-matched analysis of patients who have
undergone el-TP with patients who have type 1 diabetes has
demonstrated equivalent diabetes-specific outcomes using a
diabetes-specific quality of life tool and equivalent episodes of
hypoglycaemia, HbA1c values and mortality from diabetic com-
plications. Several recent prospective series have supported these
findings.6,7,9,14,15 In spite of these reports, the potential morbidity
associated with endocrine deficiency must not be underestimated
and specialist diabetic input should be sought in the early post-
operative period after TP. Importantly, there are several reports of
post TP deaths owing to hypoglycaemia.7,8 In previous studies
from this institution no such deaths were reported,9 although
more recently 1 patient died 53 days after el-TP from a cardiac
arrest precipitated by hypoglycaemia. This patient had suffered
several post-operative hypoglycaemic episodes in soite of special-
ist diabetic input. After TP the onset of diabetes is immediate; the
authors presume this develops with more rapidity than the onset
in patients with type 1 diabetes. Whether the presumed less rapid
onset of diabetes allows patients with type 1 diabetes to adjust to
diabetic life and risks of hypoglycaemia more safely than those
patients undergoing TP is speculation. What is clear is that
patients who undergo TPmust have exposure to specialist diabetic
team input. Ideally this should begin prior to the procedure when
possible.
Outcomes of em-TPwere significantly worse than for el-TP and
were consistent with other recent series. Muller et al. reported a
peri-operative mortality of 39% after em-TP. In addition, the high
reported rate of morbidity in the em-TP group in the present
study demonstrates the poor outcomes associated with salvage
completion pancreatectomy in the setting of severe abdominal
sepsis or haemorrhage after a pancreaticoduodenectomy. The
significant decline in the use of em-TP relative to a pancreati-
coduodenectomy reflects a shift in the management of POPF and
post-operative haemorrhage, with radiological drainage and arte-
rial embolization now readily available and preferred to
re-laparotomy (Fig. 2).16,17
The present study has several limitations. The prospectively
maintained database did not include complete data on patient
comorbidity or other measures of pre-operative performance
status meaning outcomes could not be analysed with respect to
these variables. In addition, long-term sequelae of exocrine dys-
function and the success of enzyme replacement therapy have
not been established, although diabetic and quality of life out-
comes have been evaluated, and are reported elsewhere.9 Finally,
although this study represents a large single-centre cohort, the
value of multivariate analysis was restricted by sample size.
Conclusion
The role of em-TP is declining in favour of alternative strategies
for the management of POPF and secondary haemorrhage.Whilst
the rate of el-TP relative to partial pancreatic resections is rela-
tively static, the indications for el-TP are changing and there is
evidence that short- and long-term outcomes are improving.
Although post-operative morbidity remains substantial, el-TP
should be considered an established treatment option for
multifocal neoplastic lesions with an acceptable in-hospital mor-
tality. An understanding of the post-operative exo- and endocrine
deficient states is essential and careful patient selection and coun-
selling should be undertaken whenever el-TP is considered.
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